PeerVoice Clinical Pharmacology Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

subscribe
share






The First Biologic in IBD: When, Which, and Why?


Visit https://www.peervoice.com/DHB860 to view the entire programme with slides. After completing “The First Biologic in IBD: When, Which, and Why?”, participants will be able to: Describe the clinical features and treatment goals of inflammatory bowel disease (IBD); Identify patient and drug characteristics that may influence treatment decision-making for patients with IBD; Formulate individualised treatment plans for patients with IBD who require biologic treatment, considering patient-specific factors.


fyyd: Podcast Search Engine
share








 February 13, 2021  30m